March 8, 2024
Among patients with end-stage kidney disease (ESKD) on home dialysis, pregnancy rates are higher with home hemodialysis than peritoneal dialysis, according to new research from the University of Cincinnati.
March 7, 2024
A University of Cincinnati institute selected four new projects to tackle in its second year of helping high-tech industries address their most complicated problems. UC’s Industry 4.0/5.0 Institute is dedicated to harnessing UC’s collective talent across campuses to help solve pressing issues facing businesses.
March 6, 2024
University of Cincinnati Cancer Center researchers in the lab of Jun-Lin Guan, PhD, have identified a new protein that helps prevent metastasis of a subset called HER2-positive breast cancer.
March 4, 2024
A University of Cincinnati-backed startup is developing explainable artificial intelligence to better diagnose coronary artery disease risk in women, WCPO reported.
March 4, 2024
A clinical trial led by University of Cincinnati researchers at the Lindner Center of HOPE found the drug liraglutide was safe and effective for weight loss for patients with stable bipolar disorder.
February 29, 2024
Regional media highlighted the University of Cincinnati Cancer Center being the first site in the Midwest enrolling patients in a new Phase 2 clinical trial testing a vaccine to treat pancreatic cancer.
February 29, 2024
The Atlanta Journal-Constitution highlights a UC research project that developed wearable tech capable of helping you determine compatibility from a conversation.
February 29, 2024
A University of Cincinnati Cancer Center study published in the journal JAMA Network Open found real-time navigation is a useful tool for surgeons performing ablation procedures to destroy tumors in the liver.
February 29, 2024
Researchers have demonstrated a new chemical process that grafts nanotubes to metal surfaces to create a strong, consistent, conductive link. The process opens up new possibilities for using this strong, lightweight material.
February 26, 2024
According to the National Institutes for Health, chronic sinusitis, also known as chronic rhinosinusitis (CRS), affects approximately 14.6% of the United States population and is currently the fifth most common condition treated with antibiotics, accounting for up to 22 million physician visits and costing as much as $5 billion annually. New research from the University of Cincinnati examines the incidence of people suffering from allergy symptoms who actually have CRS, a finding that could impact how those symptoms are treated. The research was published in the journal Otolaryngology - Head and Neck Surgery.